Search Results - maria+teresa+esposito

1 Results

Sort By:

Targeting acute myeloid leukaemia with Poly-ADP-ribose polymerase (PARP) inhibitors.

SummaryAcute myeloid leukemia (AML) is one of the most common cancers, accounting for about 30,000 new cases each year in the US and EU. Despite recent advances in leukemia research, AML patients are still receiving the same treatment utilised over past few decades, and have a relatively poor prognosis, with 5 year overall survival rate of only about...

Published: 11/22/2016 | Updated: 5/8/2014 | Inventor(s): Eric So, Maria Teresa Esposito

Keywords(s):

Category(s): Therapeutics